Mixed options sentiment in Novo Nordisk (NVO), with shares down $1.70 near $58.98. Options volume running well above average with 51k contracts traded and calls leading puts for a put/call ratio of 0.82, compared to a typical level near 0.55. Implied volatility (IV30) dropped 0.59 near 53.63,in the top quartile of the past year, suggesting an expected daily move of $1.99. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Novo Nordisk (NVO) will report earnings before the open on 2026-02-04.Option markets are pricing in a 50% probability of a move greater than 10.14% or $5.98.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- NVDA, GOOGL, AMZN: Trump’s Greenland Gambit Rattles Big Tech as EU Weighs Salvo
- ‘Sales and Earnings to Shrink in 2026’ TD Cowen Says of Novo Nordisk Stock (NVO)
- Novo Nordisk: Buy Rating Maintained as Pipeline Strength and Franchise Durability Outweigh 2026 Patent and Competitive Headwinds
- Novartis Stock (NVS) Holds on Upbeat View of Tariff Exposure amid U.S.-EU Tension
- These European Stocks Could Be in the Firing Line in Trump’s Greenland Tariff War